Kohei Notoya

2.1k total citations
25 papers, 1.6k citations indexed

About

Kohei Notoya is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Kohei Notoya has authored 25 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Pharmacology and 7 papers in Oncology. Recurrent topics in Kohei Notoya's work include Bone Metabolism and Diseases (8 papers), Bone health and treatments (7 papers) and Osteoarthritis Treatment and Mechanisms (6 papers). Kohei Notoya is often cited by papers focused on Bone Metabolism and Diseases (8 papers), Bone health and treatments (7 papers) and Osteoarthritis Treatment and Mechanisms (6 papers). Kohei Notoya collaborates with scholars based in Japan, Canada and China. Kohei Notoya's co-authors include Shigehisa Taketomi, Ryoichi Tsukuda, Jean‐Pierre Pelletier, Johanne Martel‐Pelletier, François Mineau, Dragan Jovanović, Pascal Reboul, Aritoshi Iida, Shiro Ikegawa and Akihiro Kotani and has published in prestigious journals such as Journal of Biological Chemistry, Nature Genetics and The Journal of Immunology.

In The Last Decade

Kohei Notoya

25 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kohei Notoya Japan	18	804	587	317	250	208	25	1.6k
John Rediske United States	17	490 0.6×	845 1.4×	531 1.7×	231 0.9×	80 0.4×	28	1.9k
Hideki Kizawa Japan	11	429 0.5×	341 0.6×	271 0.9×	120 0.5×	101 0.5×	19	1.1k
Rebecca K. Studer United States	26	458 0.6×	361 0.6×	485 1.5×	65 0.3×	67 0.3×	42	1.7k
F. Galdo Spain	15	393 0.5×	997 1.7×	337 1.1×	123 0.5×	50 0.2×	33	1.5k
M. Uchida Japan	12	302 0.4×	450 0.8×	109 0.3×	113 0.5×	130 0.6×	23	1.1k
Glenda L. Wong United States	19	1.1k 1.3×	306 0.5×	103 0.3×	592 2.4×	229 1.1×	29	2.1k
B. Caramés Spain	24	1.4k 1.7×	1.7k 2.9×	432 1.4×	232 0.9×	84 0.4×	47	3.1k
Shan‐Chi Liu Taiwan	30	895 1.1×	712 1.2×	291 0.9×	315 1.3×	50 0.2×	64	1.9k
María Isabel Guillén Spain	21	667 0.8×	364 0.6×	168 0.5×	97 0.4×	64 0.3×	33	1.3k
Hyunsoo Kim South Korea	23	1.0k 1.3×	197 0.3×	72 0.2×	466 1.9×	108 0.5×	56	1.7k

Countries citing papers authored by Kohei Notoya

Since Specialization

Citations

This map shows the geographic impact of Kohei Notoya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kohei Notoya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kohei Notoya more than expected).

Fields of papers citing papers by Kohei Notoya

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kohei Notoya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kohei Notoya. The network helps show where Kohei Notoya may publish in the future.

Co-authorship network of co-authors of Kohei Notoya

This figure shows the co-authorship network connecting the top 25 collaborators of Kohei Notoya. A scholar is included among the top collaborators of Kohei Notoya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kohei Notoya. Kohei Notoya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yoshida, Masato, Akira Mori, Shinji Morimoto, et al.. (2011). Novel and potent calcium-sensing receptor antagonists: Discovery of (5R)-N-[1-ethyl-1-(4-ethylphenyl)propyl]-2,7,7-trimethyl-5-phenyl-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide monotosylate (TAK-075) as an orally active bone anabolic agent. Bioorganic & Medicinal Chemistry. 19(6). 1881–1894. 9 indexed citations

Mototani, Hideyuki, Aritoshi Iida, Masahiro Nakajima, et al.. (2008). A functional SNP in EDG2 increases susceptibility to knee osteoarthritis in Japanese. Human Molecular Genetics. 17(12). 1790–1797. 35 indexed citations

Miyauchi, Akimitsu, Hiroshi Kamioka, Kohei Notoya, et al.. (2006). αVβ3 Integrin ligands enhance volume-sensitive calcium influx in mechanically stretched osteocytes. Journal of Bone and Mineral Metabolism. 24(6). 498–504. 49 indexed citations

Kobayashi, Tetsuya, et al.. (2005). Pioglitazone, a peroxisome proliferator–activated receptor γ agonist, reduces the progression of experimental osteoarthritis in guinea pigs. Arthritis & Rheumatism. 52(2). 479–487. 87 indexed citations

Kizawa, Hideki, Ikuyo Kou, Aritoshi Iida, et al.. (2005). An aspartic acid repeat polymorphism in asporin inhibits chondrogenesis and increases susceptibility to osteoarthritis. Nature Genetics. 37(2). 138–144. 353 indexed citations

Notoya, Kohei, et al.. (2005). Fursultiamine, a vitamin B1 derivative, enhances chondroprotective effects of glucosamine hydrochloride and chondroitin sulfate in rabbit experimental osteoarthritis. Inflammation Research. 54(6). 249–255. 15 indexed citations

Mototani, Hideyuki, Akihiko Mabuchi, Susumu Saito, et al.. (2005). A functional single nucleotide polymorphism in the core promoter region of CALM1 is associated with hip osteoarthritis in Japanese. Human Molecular Genetics. 14(8). 1009–1017. 86 indexed citations

Notoya, Kohei, et al.. (2002). Enhancement of osteogenesis in vitro by a novel osteoblast differentiation-promoting compound, TAK-778, partly through the expression of Msx2. European Journal of Pharmacology. 451(1). 19–25. 12 indexed citations

Notoya, Kohei, Dragan Jovanović, Pascal Reboul, et al.. (2000). The Induction of Cell Death in Human Osteoarthritis Chondrocytes by Nitric Oxide Is Related to the Production of Prostaglandin E2 Via the Induction of Cyclooxygenase-2. The Journal of Immunology. 165(6). 3402–3410. 201 indexed citations

10.

Saito, Kazuhiro, Kohei Notoya, Haruhiko Makino, et al.. (2000). Enhancement of fracture repair in rats with streptozotocin-induced diabetes by a single injection of biodegradable microcapsules containing a bone formation stimulant, TAK-778. Journal of Biomedical Materials Research. 51(3). 299–306. 22 indexed citations

11.

Miyauchi, Akimitsu, Kohei Notoya, Yuko Mikuni‐Takagaki, et al.. (2000). Parathyroid Hormone-activated Volume-sensitive Calcium Influx Pathways in Mechanically Loaded Osteocytes. Journal of Biological Chemistry. 275(5). 3335–3342. 77 indexed citations

12.

Oda, Tsuneo, Shigehisa Taketomi, Kohei Notoya, et al.. (1999). Studies on Disease-Modifying Antirheumatic Drugs. III. Bone Resorption Inhibitory Effects of Ethyl 4-(3,4-Dimethoxyphenyl)-6,7-dimethoxy-2-(1,2,4-triazol-1-ylmethyl)quinoline-3-carboxylate (TAK-603) and Related Compounds.. Chemical and Pharmaceutical Bulletin. 47(3). 369–374. 10 indexed citations

13.

Notoya, Kohei, et al.. (1996). Increase in femoral bone mass by ipriflavone alone and in combination with 1α-hydroxyvitamin D3 in growing rats with skeletal unloading. Calcified Tissue International. 58(2). 88–94. 9 indexed citations

14.

Miyauchi, A., Kohei Notoya, Shigehisa Taketomi, et al.. (1996). Novel ipriflavone receptors coupled to calcium influx regulate osteoclast differentiation and function.. Endocrinology. 137(8). 3544–3550. 21 indexed citations

15.

Mimura, Yusuke, S Kobayashi, Kohei Notoya, et al.. (1995). Activation by .ALPHA.1-Adrenergic Agonists of the Progression Phase in the Proliferation of Primary Cultures of Smooth Muscle Cells in Mouse and Rat Aorta.. Biological and Pharmaceutical Bulletin. 18(10). 1373–1376. 17 indexed citations

16.

Hazama, Masaaki, Kohei Notoya, Shigehisa Taketomi, et al.. (1995). Potent Ectopic Bone-Inducing Activity of Bone Morphogenetic Protein-4/7 Heterodimer. Biochemical and Biophysical Research Communications. 210(3). 670–677. 217 indexed citations

17.

Notoya, Kohei, Keiji Yoshida, Ryoichi Tsukuda, & Shigehisa Taketomi. (1994). Effect of ipriflavone on expression of markers characteristic of the osteoblast phenotype in rat bone marrow stromal cell culture. Journal of Bone and Mineral Research. 9(3). 395–400. 45 indexed citations

18.

Notoya, Kohei, Keiji Yoshida, Shigehisa Taketomi, Iwao Yamazaki, & Masayoshi Kumegawa. (1993). Inhibitory effect of ipriflavone on osteoclast-mediated bone resorption and new osteoclast formation in long-term cultures of mouse unfractionated bone cells. Calcified Tissue International. 53(3). 206–209. 27 indexed citations

19.

Notoya, Kohei, Keiji Yoshida, Shigehisa Taketomi, Iwao Yamazaki, & Masayoshi Kumegawa. (1992). Inhibitory effect of ipriflavone on pit formation in mouse unfractionated bone cells. Calcified Tissue International. 51(S1). S3–S6. 22 indexed citations

20.

Notoya, Kohei, Ryoichi Tsukuda, Keiji Yoshida, & Shigehisa Taketomi. (1992). Stimulatory effect of ipriflavone on formation of bone-like tissue in rat bone marrow stromal cell culture. Calcified Tissue International. 51(S1). S16–S20. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact